Animal models of Alport syndrome

Nephrology Dialysis Transplantation

Volumn 17, Issue 8, 2002, Pages 1359-1361

  Kashtan, Clifford E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

ALPORT SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; EDITORIAL; FEMALE; GENE EXPRESSION; GENE MUTATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; X CHROMOSOME LINKAGE; ANIMAL; DISEASE MODEL; DOMINANT GENE; GENETICS; HUMAN; NEPHRITIS; RECESSIVE GENE; X CHROMOSOME;

ANIMALS; DISEASE MODELS, ANIMAL; GENES, DOMINANT; GENES, RECESSIVE; HUMANS; NEPHRITIS, HEREDITARY; X CHROMOSOME;

EID: 0035993264     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.8.1359     Document Type: Editorial

References (29)

1. X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males
2. Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome
3. Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome
4. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation
5. Identification of a new mutation in the α4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia
6. Nonmuscle mysoin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian. Epstein and Alport-like syndromes
7. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndrome
8. Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome
9. Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome
10. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis
11. Role of distinct type IV collagen networks in glomerular development and function
12. Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: Aberrant laminin alpha2 deposition is species independent
13. Hereditary nephritis in samoyed dogs
14. Canine X chromosome-linked hereditary nephritis: A genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV
15. A new form of X-linked dominant hereditary nephritis in dogs
16. Control scheme for familial nephropathy in cocker spaniels
17. Zur familiaren nephropathie der cockerspaniel
18. Glomerular ultrastructural changes similar to hereditary nephritis in 4 English cocker spaniel dogs
19. A model of autosomal recessive Alport syndrome in English cocker spaniel dogs
20. Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome
21. Molecular and functional defects in kidneys of mice lacking collagen α3(IV): Implications for Alport syndrome
22. Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome
23. Bull terrier hereditary nephritis: A model for autosomal dominant Alport sydrome
24. Ultrastructural appearance of renal and other basement membranes in the Bull terrier model of autosomal dominant hereditary nephritis
25. Adenovirus-mediated transfer of type IV collagen alpha 5 chain cDNA into swine kidney in vivo: Deposition of the protein into the glomerular basement membrane
26. Extracellular (ECM) components in a very primitive multicellular animal, the dicyemid mesozoan Katharella antarctica
27. The α chains of type IV collagen
28. Integrin-mediated interactions between primary T-SV40 immortalized human glomerular epithelial cells and type IV collagen
29. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome